Soluble isoforms of vascular endothelial growth factor are predictors of response to sunitinib in metastatic renal cell carcinomas.

Angiogenesis is the target of several agents in the treatment of malignancies, including renal cell carcinoma (RCC). There is a real need for surrogate biomarkers that can predict selection of patients who may benefit from antiangiogenic therapies, prediction of disease outcome and which may improve...

詳細記述

書誌詳細

出版年:	PLoS ONE
主要な著者:	Bernard Paule, Laurence Bastien, Emmanuelle Deslandes, Olivier Cussenot, Marie-Pierre Podgorniak, Yves Allory, Benyoussef Naïmi, Raphael Porcher, Alexandre de La Taille, Suzanne Menashi, Fabien Calvo, Samia Mourah
フォーマット:	論文
言語:	英語
出版事項:	Public Library of Science (PLoS) 2010-05-01
オンライン･アクセス:	http://europepmc.org/articles/PMC2873294?pdf=render